Synexus Further Expands Its Global Footprint with an Acquisition in South Africa

MANCHESTER, England--(BUSINESS WIRE)--Synexus has expanded its global presence with the acquisition of a

specialist clinical trial site close to Cape Town's international

airport. This is its fourth dedicated research centre in South Africa

and brings Synexus global site count to 24 with 3 new centres being

opened in the last six months.

Synexus' continued global success is driving its international

expansion. Its order book is at a record high and continuing to grow.

The increased number of sites will ensure Synexus is able to continue to

meet increasing demands from CROs and pharma.

The new Synexus site in South Africa is the Helderberg Clinical Trials

Centre which has been in existence since 1994. It will now be known as

the Synexus Helderberg Clinical Research Centre. Dr Graham Ellis, who

founded the Centre, has been appointed Medical Director and will

continue as the Centre Manager. Dr Ellis will continue to lead an

unchanged investigator and clinical team.

Dr Ellis is considered an international expert in the field of diabetes

and osteoporosis in South Africa and is often consulted locally and

internationally by pharmaceutical companies. The Helderberg Centre has a

strong track record of service performance and has completed over 150

clinical trials (including Phase 2, 3 and 4 studies). The main areas of

experience include diabetes, osteoporosis, COPD, cardiovascular and

infectious diseases.

Dr Christophe Berthoux, CEO of Synexus says: "This is yet another new

development that we have put in place to meet the increasing demands of

the pharma industry for our high quality professional services. Our

order book is at a record high and continuing to grow.

"We have long recognised the vital role South Africa has to play in

global clinical trials as this addition to our portfolio and continued

investment in the region is testament to that. South Africa provides

access to a large patient pool, excellent medical infrastructure and the

training of the medical staff at all levels is of a very high standard.

There is also a high public awareness of the benefits of clinical trials

which speeds up recruitment and overcomes the lengthy regulatory

process. These are all key factors in ensuring the success of a clinical

trial."

http://www.businesswire.com/news/home/20140827005853/en/Synexus-Expands-Global-Footprint-Acquisition-South-Africa